Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma - Morschhauser, F; Radford, J; Van Hoof, A (J Clin Oncol, 2008)
et al.